Journal of Isfahan Medical School

Journal of Isfahan Medical School

The Association of TMPRSS6rs4820268 Polymorphism with Iron Deficiency Anemia among the Population of Kurdistan: A Case Control Study

Authors
Asra Maleki 1
Bahram Nikkhoo 2
Fatemeh Keshavarzi 3
1 MSc, Kurdistan Science and Research Branch, Department of Biology, Islamic Azad University, Sanandaj, Iran
2 Associate Professor, Department of Pathology and Clinical Laboratory, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
3 Associate Professor, Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran
10.48305/jims.2022.16289
Abstract
Background: Anemia is a condition in which the concentration of hemoglobin (Hb) or red blood cell count (RBC) is lower than normal and is not sufficient to meet the physiological needs of the individual. Several genetic polymorphisms associated with iron status have been identified. The aim of this study was to investigate the relationship between rs4820268G > A polymorphism and iron deficiency anemia in Sanandaj. 
Methods: In this case-control study, 120 individuals including 40 patients with iron deficiency anemia (based on the results of ferritin test; hemoglobin, CBC and MCV) alongside 80 healthy individuals were studied. After DNA extraction, genotypes of individuals were examined by RFLP-PCR technique and the effect of HPY99I enzyme.
Findings: The frequency of AA, AG and GG genotypes among patients were (25) 25, (4) 10 and (26) 65% and in healthy group (57) 71.25, (17) 21.25 and (6) 5/ 7%, respectively. The odds ratio (OR) of the genotype, GG, is 22 times higher than that of AA. Also, the Hardy-Weinberg test showed a balanced population in this analysis.
Conclusion: The results showed a significant relationship between GG and AA genotypes with disease and health, respectively (P < 0.001). In other words, individual with GG genotype had lower Hb, MCV and Ferritin than people with AA and AG genotypes.
Keywords
Iron deficiency anemia
Single nucleotide polymorphism
TMPRSS6 rs4820268
  1. Allison J, Drury L, Ford JB. Two novel TMPRSS6 variants in a compound heterozygous child with iron refractory iron deficiency anemia. J Pediatr Hematol Oncol 2020; 4(4): e238-9.
  2. Finberg KE, Whittlesey RL, Fleming MD, Andrews NC. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 2010; 115(18): 3817-26.
  3. Ramsay AJ, Quesada V, Sanchez M, Garabaya C, Sardà MP, Baiget M, et al. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum Mol Gen 2009; 18(19): 3673-83.
  4. An P, Wu Q, Wang H, Guan Y, Mu M, Liao Y, et al. TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia. Hum Mol Genet 2012; 21(9): 2124-31.
  5. Nalado AM, Dickens C, Dix-Peek T, Mahlangu N, Olorunfemi G, Paget G, et al. MPRSS6 rs855791 polymorphism and susceptibility to iron deficiency anaemia in non-dialysis chronic kidney disease patients in South Africa. Int J Mol Epidemiol Genet 2019; 10(1): 1-9.
  6. Benyamin B, Ferreira MA, Willemsen G, Gordan S, Middelberg R, McEvoy BP, et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 2009; 41(11): 1173-5.
  7. Çakmakli S, Acipayam C, Yenmiş İnan MN, Doğan H. Iron refractory iron deficiency anemia due to 374 base pairs deletion in the tmprss6 gene. J Pediatr Hematol Oncol 2019; 41(5): e333-e335.
  8. Fairweather-Tait SJ, Guile GR, Valdes AM, Wawer AA, Hurst R, Skinner J, et al. The contribution of diet and genotype to iron status in women: a classical twin study. PLoS One 2013; 8(12): e83047.
  9. Batar B, Bavunogl I, Hacioglu Y, Cengiz M, Mutlu T, Yavuzer S, et al. The role of TMPRSS6 gene variants in iron-related hematological parameters in Turkish patients with iron deficiency anemia. Gene 2018; 673: 201-5.
  10. Al-Amer O, Hawasawi Y, Oyouni AAA, Alshehri M, Alasmari A, Alzahrani O, et al. Study the association of transmembrane serine protease 6 gene polymorphisms with iron deficiency status in Saudi Arabia. Gene 2020; 751: 144767.
  11. Shinta D, Asmarinah, Adhiyanto C, Htet MK, Fahmida U. The association of TMPRSS6 gene polymorphism and iron intake with iron status among under-two-year-old children in Lombok, Indonesia. Nutrients 2019; 11(878): 878.
  12. Lan Q, Shen M, Garcia-Rossi D, Chanock S, Zheng T, Berndt SI, et al. Genotype frequency and F ST analysis of polymorphisms Role of matriptase-2 (TMPRSS6) in iron metabolism. Acta Haematol 2007; 122: 87-96.
  13. Tanaka T, Roy CN, Franco OH, Matteini A, Semba RD, Arking D, et al. A genome-wide association analysis of serum iron concentrations. Blood 2010; 115(1): 94-6.
  14. Ye X, Yu Z, Li H, Shah T, Min DI, Liu Y, et al. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007; 49(17): 1798-805.
  15. Delbini P, Vaja V, Graziadei G, Duca L, Nava I, Refaldi C, et al. Genetic variability of TMPRSS6 and its association with iron deficiency anaemia. Br J Haematol 2010; 151(3): 281-4.
  16. Lewis SJ, Bonilla C, Brion MJ, Lawlor DA, Gunnell D, Ben-Shlomo Y, et al. Maternal iron levels early in pregnancy are not associated with offspring IQ score at age 8, findings from a Mendelian randomization study. Eur J Clin Nutr 2014; 68(4): 496-502.
  17. Webb SL, Sanders AJ, Mason MD, Jiang WJ. Type II transmembrane serine protease (TTSP) deregulation in cancer. Front Biosci (Landmark Ed). 2011; 16(2): 539-52.
  18. Webb S, Sanders AJ, Mason MD, Jiang WJ. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin. Oncology Reports 2012; 28(4): 1491-7.
  19. Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma VM, et al. Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population. Clin Cancer Res 2006; 12(5): 1454-62.
  20. Sanders AJ, Parr C, Martin TA, Lane J, Mason MD, Jiang WG. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate can- cer cells in vitro and in vivo and affects FAK and paxillin localisation. J Cell Physiol 2008; 216(3): 780-9.
Journal of Isfahan Medical School
Volume 40, Issue 659
3rd Week, April
March and April 2022
Pages 55-61

  • Receive Date 14 April 2022